Renal Cell Carcinoma, Gp200-MR6 antibody

Catalog No. ABIN2350037

The Mouse Monoclonal anti-Renal Cell Carcinoma, Gp200-MR6 antibody has been validated for FACS and ELISA. It is suitable to detect Renal Cell Carcinoma, Gp200-MR6 in samples from Human.

Quick Overview for Renal Cell Carcinoma, Gp200-MR6 antibody (ABIN2350037)

Target: Renal Cell Carcinoma, Gp200-MR6

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Flow Cytometry (FACS), ELISA

Clone: 9H176

Product Details

Cross-Reactivity: Human

Cross-Reactivity (Details): Calculated cross reactivity: Hu

Characteristics: Renal Cell Carcinoma, gp200-MR6 (CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY-75, Podocalyxin)

Purification: Purified by Protein G affinity chromatography.

Immunogen: E. coli-derived rhDEC-205

Isotype: IgG1

Application Details

Application Notes: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with 200 μL sterile PBS.

Buffer: Supplied as a lyophilized powder from PBS, 5 % trehalose.

Storage: -20 °C

Storage Comment: -20°C

Target Details

Target: Renal Cell Carcinoma, Gp200-MR6